Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ...
For decades, Indian students have been told that an honours degree is the safer, smarter choice. It sounds more rigorous, ...
Background Hypertension is a major cause of premature death worldwide, controlled by only one in five adults. Two trials ...
Morning Overview on MSN
Lab mice released into nature reveal a lesson you won’t forget
When laboratory mice step out of their plastic cages and into real soil, their behavior changes so dramatically that it forces a rethink of what stress, health and even “normal” really mean. The story ...
The Daily Overview on MSN
White House says Kennedy Center to be renamed Trump-Kennedy Center
The White House's declaration that the Kennedy Center will carry President Donald Trump's name alongside John F. Kennedy's ...
Discover the latest breakthroughs in myasthenia gravis treatment, including rozanolixizumab and nipocalimab, and insights on ...
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company's First FDA-Approv ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results